In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
INTERPRETATION[Updated] Drug Application Fees for FY 2023 in China and the U.S.
Feb 10, 2023
Q&AChina CDE Q&A | Biologics' R&D, Associated Review of APIs, Excipients, and Packaging Materials, Requirements for Changes, and More
Sep 05, 2022
Q&AChina CDE Q&A | BE Study, Reference Listed Drug, and Quality & Therapeutic Equivalence Evaluation
Aug 30, 2022
REPORT2021 China CDE Drug Evaluation Report
Jul 04, 2022
INTERPRETATIONChina Drug Master File (DMF) for APIs, Pharmaceutical Excipients & Packaging Materials
May 07, 2021
REPORTSelection of 2019 China Center for Drug Evaluation Annual Report
Mar 08, 2021